One of these is retatrutide, a drug that’s being described as the next big thing in weight loss. Some say it may be even more ...

My social media feed has been blowing up over what’s being predicted to become a “trillion-dollar drug,” — Retatrutide, a.k.a. “Reta” a.k.a. “GLP-3” Retatrutide represents the third generation of ...

After several tireless days we have finished crunching the numbers from nearly 900 13F filings issued by the elite hedge funds and other investment firms that we track at Insider Monkey, which ...

In recent trading, shares of Reata Pharmaceuticals Inc (Symbol: RETA) have crossed above the average analyst 12-month target price of $119.18, changing hands for $167.19/share. When a stock reaches ...

Reata Pharmaceuticals (NASDAQ:RETA) lost ~32% on Monday to reach the lowest level in over four months as a key FDA official leaves the agency while the company awaits the U.S. approval for its ...